Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).
about
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies.Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.Impact of hormone therapy on Medicare spending in the Women's Health Initiative randomized clinical trials.Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).
P2860
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cost-effectiveness of Simvasta ...... and Renal Protection (SHARP).
@ast
Cost-effectiveness of Simvasta ...... and Renal Protection (SHARP).
@en
type
label
Cost-effectiveness of Simvasta ...... and Renal Protection (SHARP).
@ast
Cost-effectiveness of Simvasta ...... and Renal Protection (SHARP).
@en
prefLabel
Cost-effectiveness of Simvasta ...... and Renal Protection (SHARP).
@ast
Cost-effectiveness of Simvasta ...... and Renal Protection (SHARP).
@en
P2093
P2860
P50
P1476
Cost-effectiveness of Simvasta ...... t and Renal Protection (SHARP)
@en
P2093
Alastair Gray
Christina Reith
Colin Baigent
Jonathan Craig
Jonathan Emberson
Martin J Landray
Rory Collins
SHARP Collaborative Group
Seamus Kent
P2860
P304
P356
10.1053/J.AJKD.2015.09.020
P577
2015-11-18T00:00:00Z